Cancer is the second most common cause of death in the United States, trailing only heart
disease in incidence. Despite significant worldwide investment in research, cancer remains …

Despite recent progress in the treatment of cancer, the majority of cases are still diagnosed
only after tumors have metastasized, leaving the patient with a grim prognosis. However …

2. INTRODUCTION The investigation of many fundamental processes in life sciences
requires straightforward tools for fast, sensitive, reliable, and reproducible detection of …

The application of nanotechnology to medicine, commonly referred to as 'nanomedicine',
has the potential to transform our approach to human health and disease. Research at the …

Innovation in the last decade has endowed nanotechnology with an assortment of tools for
delivery, imaging, and sensing in cancer research—stealthy nanoparticle vectors circulating …

Cancer biomarkers with high selectivity, specificity and reproducibility play essential role in
diagnosis, prognosis and prediction of treatment efficacy in cancer patients. However, the …

Fluorescent nanoparticles (NPs), including semiconductor NPs (Quantum Dots), metal NPs,
silica NPs, polymer NPs, etc., have been a major focus of research and development during …

The use of in vivo near‐infrared fluorescence (NIRF) imaging techniques for sensitive
cancer early detection is highly desirable, because biological tissues show very low …

Recent advances in molecular imaging and nanotechnology are providing new
opportunities for biomedical imaging with great promise for the development of novel …

Despite the progress in developing new therapeutic modalities, cancer remains one of the
leading diseases causing human mortality. This is mainly attributed to the inability to …